Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1Q60
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,292
Award facts
- Contract value 100% obligated
- $12,291.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,291.69 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on December 18, 2025, with completion scheduled for December 19, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
XELJANZ XR is a rheumatoid arthritis treatment, and this order exemplifies the broad pharmaceutical portfolio that AmerisourceBergen delivers through its DLA contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The delivery order demonstrates the company's ongoing role as a primary supplier for military and veteran healthcare systems, leveraging its global pharmaceutical support capabilities to fulfill federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F1Q60?
SPE2DR26F1Q60 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F1Q60 worth?
The government has obligated $12,292 on SPE2DR26F1Q60.
Is contract SPE2DR26F1Q60 an order under another contract?
Yes. SPE2DR26F1Q60 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Q60 competed?
The extent of competition for SPE2DR26F1Q60 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award